nodes	percent_of_prediction	percent_of_DWPC	metapath
Midazolam—CYP2E1—lung cancer	0.195	0.656	CbGaD
Midazolam—ABCB1—lung cancer	0.102	0.344	CbGaD
Midazolam—CYP3A5—Gefitinib—lung cancer	0.0216	0.0516	CbGbCtD
Midazolam—CYP3A5—Teniposide—lung cancer	0.021	0.0501	CbGbCtD
Midazolam—CYP3A7-CYP3A51P—Paclitaxel—lung cancer	0.0156	0.0373	CbGbCtD
Midazolam—CYP3A7—Paclitaxel—lung cancer	0.0156	0.0373	CbGbCtD
Midazolam—CYP3A7-CYP3A51P—Irinotecan—lung cancer	0.0154	0.0368	CbGbCtD
Midazolam—CYP3A7—Irinotecan—lung cancer	0.0154	0.0368	CbGbCtD
Midazolam—ABCB1—Topotecan—lung cancer	0.0154	0.0367	CbGbCtD
Midazolam—CYP2B6—Irinotecan—lung cancer	0.0147	0.035	CbGbCtD
Midazolam—ABCB1—Gefitinib—lung cancer	0.0141	0.0336	CbGbCtD
Midazolam—CYP3A5—Crizotinib—lung cancer	0.0132	0.0316	CbGbCtD
Midazolam—CYP3A5—Erlotinib—lung cancer	0.0128	0.0305	CbGbCtD
Midazolam—CYP2B6—Cisplatin—lung cancer	0.0119	0.0285	CbGbCtD
Midazolam—CYP2E1—Etoposide—lung cancer	0.0119	0.0284	CbGbCtD
Midazolam—CYP3A5—Paclitaxel—lung cancer	0.0117	0.0279	CbGbCtD
Midazolam—CYP3A5—Irinotecan—lung cancer	0.0115	0.0276	CbGbCtD
Midazolam—CYP3A7-CYP3A51P—Docetaxel—lung cancer	0.0113	0.0269	CbGbCtD
Midazolam—CYP3A7—Docetaxel—lung cancer	0.0113	0.0269	CbGbCtD
Midazolam—ABCB1—Vinorelbine—lung cancer	0.0108	0.0259	CbGbCtD
Midazolam—CYP3A5—Etoposide—lung cancer	0.00924	0.0221	CbGbCtD
Midazolam—CYP3A4—Topotecan—lung cancer	0.00922	0.022	CbGbCtD
Midazolam—ABCB1—Crizotinib—lung cancer	0.00862	0.0206	CbGbCtD
Midazolam—CYP3A5—Docetaxel—lung cancer	0.00846	0.0202	CbGbCtD
Midazolam—CYP3A4—Gefitinib—lung cancer	0.00843	0.0201	CbGbCtD
Midazolam—ABCB1—Gemcitabine—lung cancer	0.00843	0.0201	CbGbCtD
Midazolam—ABCB1—Erlotinib—lung cancer	0.00832	0.0199	CbGbCtD
Midazolam—CYP3A4—Teniposide—lung cancer	0.00817	0.0195	CbGbCtD
Midazolam—CYP2B6—Doxorubicin—lung cancer	0.008	0.0191	CbGbCtD
Midazolam—ABCB1—Paclitaxel—lung cancer	0.00761	0.0182	CbGbCtD
Midazolam—ABCB1—Irinotecan—lung cancer	0.00751	0.0179	CbGbCtD
Midazolam—ABCB1—Vinblastine—lung cancer	0.00668	0.016	CbGbCtD
Midazolam—CYP3A4—Vinorelbine—lung cancer	0.00649	0.0155	CbGbCtD
Midazolam—ABCB1—Cisplatin—lung cancer	0.00612	0.0146	CbGbCtD
Midazolam—ABCB1—Etoposide—lung cancer	0.00602	0.0144	CbGbCtD
Midazolam—ABCB1—Docetaxel—lung cancer	0.00551	0.0132	CbGbCtD
Midazolam—CYP3A4—Crizotinib—lung cancer	0.00517	0.0123	CbGbCtD
Midazolam—CYP3A4—Erlotinib—lung cancer	0.00498	0.0119	CbGbCtD
Midazolam—CYP3A4—Paclitaxel—lung cancer	0.00456	0.0109	CbGbCtD
Midazolam—CYP3A4—Irinotecan—lung cancer	0.0045	0.0108	CbGbCtD
Midazolam—ABCB1—Doxorubicin—lung cancer	0.0041	0.0098	CbGbCtD
Midazolam—CYP3A4—Vinblastine—lung cancer	0.004	0.00956	CbGbCtD
Midazolam—ABCB1—Methotrexate—lung cancer	0.00398	0.0095	CbGbCtD
Midazolam—CYP3A4—Etoposide—lung cancer	0.0036	0.00861	CbGbCtD
Midazolam—CYP3A4—Docetaxel—lung cancer	0.0033	0.00788	CbGbCtD
Midazolam—CYP3A4—Doxorubicin—lung cancer	0.00246	0.00587	CbGbCtD
Midazolam—UGT1A4—respiratory system—lung cancer	0.00121	0.0788	CbGeAlD
Midazolam—CYP4B1—respiratory system—lung cancer	0.0012	0.0778	CbGeAlD
Midazolam—GABRP—mammary gland—lung cancer	0.00101	0.0657	CbGeAlD
Midazolam—CYP4B1—bronchus—lung cancer	0.000986	0.064	CbGeAlD
Midazolam—CYP4B1—trachea—lung cancer	0.000885	0.0575	CbGeAlD
Midazolam—CYP4B1—cardiac atrium—lung cancer	0.000832	0.054	CbGeAlD
Midazolam—GABRE—mammary gland—lung cancer	0.000772	0.0501	CbGeAlD
Midazolam—GABRP—respiratory system—lung cancer	0.000674	0.0438	CbGeAlD
Midazolam—CYP4B1—lung—lung cancer	0.000636	0.0413	CbGeAlD
Midazolam—GABRP—bronchus—lung cancer	0.000555	0.036	CbGeAlD
Midazolam—GABRP—trachea—lung cancer	0.000498	0.0324	CbGeAlD
Midazolam—GABRB3—respiratory system—lung cancer	0.000436	0.0283	CbGeAlD
Midazolam—CYP4B1—lymph node—lung cancer	0.000435	0.0282	CbGeAlD
Midazolam—GABRE—bronchus—lung cancer	0.000424	0.0275	CbGeAlD
Midazolam—GABRE—trachea—lung cancer	0.00038	0.0247	CbGeAlD
Midazolam—GABRP—lung—lung cancer	0.000358	0.0232	CbGeAlD
Midazolam—GABRE—cardiac atrium—lung cancer	0.000357	0.0232	CbGeAlD
Midazolam—GABRR2—lymph node—lung cancer	0.00035	0.0227	CbGeAlD
Midazolam—Flunitrazepam—UGT1A1—lung cancer	0.000322	0.173	CrCbGaD
Midazolam—GABRB2—lung—lung cancer	0.000302	0.0196	CbGeAlD
Midazolam—CYP3A5—respiratory system—lung cancer	0.000298	0.0193	CbGeAlD
Midazolam—CYP2B6—respiratory system—lung cancer	0.000296	0.0192	CbGeAlD
Midazolam—CYP2E1—respiratory system—lung cancer	0.000278	0.018	CbGeAlD
Midazolam—GABRE—lung—lung cancer	0.000273	0.0177	CbGeAlD
Midazolam—CYP2B6—bronchus—lung cancer	0.000243	0.0158	CbGeAlD
Midazolam—GABRB3—lung—lung cancer	0.000232	0.015	CbGeAlD
Midazolam—Flunitrazepam—CYP2A6—lung cancer	0.000202	0.109	CrCbGaD
Midazolam—GABRA2—lymph node—lung cancer	0.000189	0.0122	CbGeAlD
Midazolam—GABRE—lymph node—lung cancer	0.000187	0.0121	CbGeAlD
Midazolam—Clonazepam—CYP2E1—lung cancer	0.000179	0.0963	CrCbGaD
Midazolam—Flurazepam—CYP2A6—lung cancer	0.000162	0.0874	CrCbGaD
Midazolam—ABCB1—respiratory system—lung cancer	0.000158	0.0103	CbGeAlD
Midazolam—CYP3A5—lung—lung cancer	0.000158	0.0103	CbGeAlD
Midazolam—CYP2B6—lung—lung cancer	0.000157	0.0102	CbGeAlD
Midazolam—CYP2E1—lung—lung cancer	0.000147	0.00957	CbGeAlD
Midazolam—Flunitrazepam—CYP2E1—lung cancer	0.000143	0.0773	CrCbGaD
Midazolam—ABCB1—epithelium—lung cancer	0.000132	0.00858	CbGeAlD
Midazolam—Ketazolam—ALB—lung cancer	0.000122	0.0656	CrCbGaD
Midazolam—Vertigo—Paclitaxel—lung cancer	0.000119	0.000832	CcSEcCtD
Midazolam—Syncope—Paclitaxel—lung cancer	0.000119	0.000831	CcSEcCtD
Midazolam—Lethargy—Doxorubicin—lung cancer	0.000119	0.00083	CcSEcCtD
Midazolam—Rash—Topotecan—lung cancer	0.000118	0.000828	CcSEcCtD
Midazolam—Hypersensitivity—Vinorelbine—lung cancer	0.000118	0.000828	CcSEcCtD
Midazolam—Dermatitis—Topotecan—lung cancer	0.000118	0.000828	CcSEcCtD
Midazolam—Vomiting—Erlotinib—lung cancer	0.000118	0.000826	CcSEcCtD
Midazolam—Dyspnoea—Irinotecan—lung cancer	0.000118	0.000826	CcSEcCtD
Midazolam—Nervous system disorder—Cisplatin—lung cancer	0.000118	0.000825	CcSEcCtD
Midazolam—Cough—Etoposide—lung cancer	0.000118	0.000824	CcSEcCtD
Midazolam—Somnolence—Irinotecan—lung cancer	0.000118	0.000824	CcSEcCtD
Midazolam—Headache—Topotecan—lung cancer	0.000118	0.000823	CcSEcCtD
Midazolam—Tachycardia—Cisplatin—lung cancer	0.000117	0.000821	CcSEcCtD
Midazolam—Rash—Erlotinib—lung cancer	0.000117	0.000819	CcSEcCtD
Midazolam—Dermatitis—Erlotinib—lung cancer	0.000117	0.000819	CcSEcCtD
Midazolam—ABCB1—trachea—lung cancer	0.000117	0.00759	CbGeAlD
Midazolam—Skin disorder—Cisplatin—lung cancer	0.000117	0.000817	CcSEcCtD
Midazolam—Dyspepsia—Irinotecan—lung cancer	0.000117	0.000816	CcSEcCtD
Midazolam—Immune system disorder—Docetaxel—lung cancer	0.000116	0.000815	CcSEcCtD
Midazolam—Headache—Erlotinib—lung cancer	0.000116	0.000814	CcSEcCtD
Midazolam—Diplopia—Doxorubicin—lung cancer	0.000116	0.000814	CcSEcCtD
Midazolam—Osteoarthritis—Doxorubicin—lung cancer	0.000116	0.000814	CcSEcCtD
Midazolam—Ketazolam—ABCB1—lung cancer	0.000116	0.0626	CrCbGaD
Midazolam—Mediastinal disorder—Docetaxel—lung cancer	0.000116	0.000813	CcSEcCtD
Midazolam—Paraesthesia—Gemcitabine—lung cancer	0.000116	0.000811	CcSEcCtD
Midazolam—Chills—Docetaxel—lung cancer	0.000116	0.000809	CcSEcCtD
Midazolam—Cough—Paclitaxel—lung cancer	0.000116	0.000808	CcSEcCtD
Midazolam—Asthenia—Vinorelbine—lung cancer	0.000115	0.000806	CcSEcCtD
Midazolam—Flurazepam—CYP2E1—lung cancer	0.000115	0.062	CrCbGaD
Midazolam—Dyspnoea—Gemcitabine—lung cancer	0.000115	0.000805	CcSEcCtD
Midazolam—Nausea—Vinblastine—lung cancer	0.000115	0.000803	CcSEcCtD
Midazolam—Somnolence—Gemcitabine—lung cancer	0.000115	0.000803	CcSEcCtD
Midazolam—Affect lability—Doxorubicin—lung cancer	0.000114	0.000801	CcSEcCtD
Midazolam—Gastrointestinal disorder—Irinotecan—lung cancer	0.000114	0.0008	CcSEcCtD
Midazolam—Fatigue—Irinotecan—lung cancer	0.000114	0.000799	CcSEcCtD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Etoposide—lung cancer	0.000114	0.000799	CcSEcCtD
Midazolam—Pruritus—Vinorelbine—lung cancer	0.000114	0.000795	CcSEcCtD
Midazolam—Constipation—Irinotecan—lung cancer	0.000113	0.000793	CcSEcCtD
Midazolam—Pain—Irinotecan—lung cancer	0.000113	0.000793	CcSEcCtD
Midazolam—Mental disorder—Docetaxel—lung cancer	0.000113	0.00079	CcSEcCtD
Midazolam—Hypotension—Cisplatin—lung cancer	0.000112	0.000786	CcSEcCtD
Midazolam—Anxiety—Paclitaxel—lung cancer	0.000112	0.000786	CcSEcCtD
Midazolam—Erythema—Docetaxel—lung cancer	0.000112	0.000785	CcSEcCtD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—lung cancer	0.000112	0.000783	CcSEcCtD
Midazolam—Nausea—Topotecan—lung cancer	0.000112	0.00078	CcSEcCtD
Midazolam—Gastrointestinal disorder—Gemcitabine—lung cancer	0.000111	0.000779	CcSEcCtD
Midazolam—Fatigue—Gemcitabine—lung cancer	0.000111	0.000778	CcSEcCtD
Midazolam—Confusional state—Etoposide—lung cancer	0.000111	0.000777	CcSEcCtD
Midazolam—Cardiac arrest—Doxorubicin—lung cancer	0.000111	0.000774	CcSEcCtD
Midazolam—Constipation—Gemcitabine—lung cancer	0.00011	0.000772	CcSEcCtD
Midazolam—Pain—Gemcitabine—lung cancer	0.00011	0.000772	CcSEcCtD
Midazolam—Nausea—Erlotinib—lung cancer	0.00011	0.000772	CcSEcCtD
Midazolam—Dry mouth—Paclitaxel—lung cancer	0.00011	0.000771	CcSEcCtD
Midazolam—Anaphylactic shock—Etoposide—lung cancer	0.00011	0.000771	CcSEcCtD
Midazolam—Mood swings—Doxorubicin—lung cancer	0.00011	0.000771	CcSEcCtD
Midazolam—Ataxia—Doxorubicin—lung cancer	0.000109	0.000765	CcSEcCtD
Midazolam—Feeling abnormal—Irinotecan—lung cancer	0.000109	0.000764	CcSEcCtD
Midazolam—Confusional state—Paclitaxel—lung cancer	0.000109	0.000762	CcSEcCtD
Midazolam—Anaphylactic shock—Paclitaxel—lung cancer	0.000108	0.000756	CcSEcCtD
Midazolam—Paraesthesia—Cisplatin—lung cancer	0.000108	0.000756	CcSEcCtD
Midazolam—Tachycardia—Etoposide—lung cancer	0.000108	0.000752	CcSEcCtD
Midazolam—Dyspnoea—Cisplatin—lung cancer	0.000107	0.00075	CcSEcCtD
Midazolam—Skin disorder—Etoposide—lung cancer	0.000107	0.000749	CcSEcCtD
Midazolam—Feeling abnormal—Gemcitabine—lung cancer	0.000106	0.000744	CcSEcCtD
Midazolam—Shock—Paclitaxel—lung cancer	0.000106	0.000744	CcSEcCtD
Midazolam—Dizziness—Vinorelbine—lung cancer	0.000106	0.000743	CcSEcCtD
Midazolam—Nervous system disorder—Paclitaxel—lung cancer	0.000106	0.000741	CcSEcCtD
Midazolam—Tachycardia—Paclitaxel—lung cancer	0.000105	0.000738	CcSEcCtD
Midazolam—Skin disorder—Paclitaxel—lung cancer	0.000105	0.000734	CcSEcCtD
Midazolam—Nasopharyngitis—Doxorubicin—lung cancer	0.000104	0.000727	CcSEcCtD
Midazolam—Gastrointestinal disorder—Cisplatin—lung cancer	0.000104	0.000726	CcSEcCtD
Midazolam—Drowsiness—Methotrexate—lung cancer	0.000103	0.000724	CcSEcCtD
Midazolam—Depression—Methotrexate—lung cancer	0.000103	0.000722	CcSEcCtD
Midazolam—Hypotension—Etoposide—lung cancer	0.000103	0.00072	CcSEcCtD
Midazolam—Pain—Cisplatin—lung cancer	0.000103	0.00072	CcSEcCtD
Midazolam—Muscular weakness—Doxorubicin—lung cancer	0.000103	0.000718	CcSEcCtD
Midazolam—Vomiting—Vinorelbine—lung cancer	0.000102	0.000715	CcSEcCtD
Midazolam—Rash—Vinorelbine—lung cancer	0.000101	0.000709	CcSEcCtD
Midazolam—Dermatitis—Vinorelbine—lung cancer	0.000101	0.000708	CcSEcCtD
Midazolam—Hypotension—Paclitaxel—lung cancer	0.000101	0.000706	CcSEcCtD
Midazolam—Headache—Vinorelbine—lung cancer	0.000101	0.000704	CcSEcCtD
Midazolam—Syncope—Docetaxel—lung cancer	0.000101	0.000704	CcSEcCtD
Midazolam—Feeling abnormal—Cisplatin—lung cancer	9.91e-05	0.000693	CcSEcCtD
Midazolam—Paraesthesia—Etoposide—lung cancer	9.89e-05	0.000692	CcSEcCtD
Midazolam—Dyspnoea—Etoposide—lung cancer	9.82e-05	0.000687	CcSEcCtD
Midazolam—Clonazepam—ALB—lung cancer	9.82e-05	0.0529	CrCbGaD
Midazolam—Somnolence—Etoposide—lung cancer	9.8e-05	0.000685	CcSEcCtD
Midazolam—Cough—Docetaxel—lung cancer	9.79e-05	0.000685	CcSEcCtD
Midazolam—Hypersensitivity—Irinotecan—lung cancer	9.76e-05	0.000683	CcSEcCtD
Midazolam—Paraesthesia—Paclitaxel—lung cancer	9.7e-05	0.000679	CcSEcCtD
Midazolam—Dyspnoea—Paclitaxel—lung cancer	9.63e-05	0.000674	CcSEcCtD
Midazolam—Somnolence—Paclitaxel—lung cancer	9.6e-05	0.000672	CcSEcCtD
Midazolam—Nausea—Vinorelbine—lung cancer	9.54e-05	0.000668	CcSEcCtD
Midazolam—Gastrointestinal disorder—Etoposide—lung cancer	9.51e-05	0.000666	CcSEcCtD
Midazolam—Dyspepsia—Paclitaxel—lung cancer	9.51e-05	0.000665	CcSEcCtD
Midazolam—Asthenia—Irinotecan—lung cancer	9.5e-05	0.000665	CcSEcCtD
Midazolam—Fatigue—Etoposide—lung cancer	9.5e-05	0.000665	CcSEcCtD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	9.49e-05	0.000664	CcSEcCtD
Midazolam—Constipation—Etoposide—lung cancer	9.42e-05	0.000659	CcSEcCtD
Midazolam—Pain—Etoposide—lung cancer	9.42e-05	0.000659	CcSEcCtD
Midazolam—Dry mouth—Docetaxel—lung cancer	9.34e-05	0.000654	CcSEcCtD
Midazolam—Gastrointestinal disorder—Paclitaxel—lung cancer	9.33e-05	0.000653	CcSEcCtD
Midazolam—Fatigue—Paclitaxel—lung cancer	9.31e-05	0.000652	CcSEcCtD
Midazolam—ABCB1—bone marrow—lung cancer	9.27e-05	0.00602	CbGeAlD
Midazolam—Asthenia—Gemcitabine—lung cancer	9.26e-05	0.000648	CcSEcCtD
Midazolam—Constipation—Paclitaxel—lung cancer	9.24e-05	0.000646	CcSEcCtD
Midazolam—Pain—Paclitaxel—lung cancer	9.24e-05	0.000646	CcSEcCtD
Midazolam—Confusional state—Docetaxel—lung cancer	9.23e-05	0.000646	CcSEcCtD
Midazolam—Anaphylactic shock—Docetaxel—lung cancer	9.16e-05	0.000641	CcSEcCtD
Midazolam—Diazepam—CYP2E1—lung cancer	9.15e-05	0.0493	CrCbGaD
Midazolam—Pruritus—Gemcitabine—lung cancer	9.13e-05	0.000639	CcSEcCtD
Midazolam—Feeling abnormal—Etoposide—lung cancer	9.08e-05	0.000635	CcSEcCtD
Midazolam—Shock—Docetaxel—lung cancer	9.01e-05	0.00063	CcSEcCtD
Midazolam—Nervous system disorder—Docetaxel—lung cancer	8.98e-05	0.000628	CcSEcCtD
Midazolam—Drowsiness—Doxorubicin—lung cancer	8.96e-05	0.000627	CcSEcCtD
Midazolam—Visual impairment—Methotrexate—lung cancer	8.95e-05	0.000626	CcSEcCtD
Midazolam—Tachycardia—Docetaxel—lung cancer	8.94e-05	0.000625	CcSEcCtD
Midazolam—Feeling abnormal—Paclitaxel—lung cancer	8.9e-05	0.000623	CcSEcCtD
Midazolam—Skin disorder—Docetaxel—lung cancer	8.89e-05	0.000622	CcSEcCtD
Midazolam—Hypersensitivity—Cisplatin—lung cancer	8.86e-05	0.00062	CcSEcCtD
Midazolam—Neuropathy peripheral—Doxorubicin—lung cancer	8.78e-05	0.000615	CcSEcCtD
Midazolam—Dizziness—Irinotecan—lung cancer	8.76e-05	0.000613	CcSEcCtD
Midazolam—Urticaria—Etoposide—lung cancer	8.75e-05	0.000612	CcSEcCtD
Midazolam—Eye disorder—Methotrexate—lung cancer	8.68e-05	0.000607	CcSEcCtD
Midazolam—Asthenia—Cisplatin—lung cancer	8.63e-05	0.000604	CcSEcCtD
Midazolam—Cardiac disorder—Methotrexate—lung cancer	8.62e-05	0.000603	CcSEcCtD
Midazolam—Urticaria—Paclitaxel—lung cancer	8.58e-05	0.0006	CcSEcCtD
Midazolam—Hypotension—Docetaxel—lung cancer	8.56e-05	0.000599	CcSEcCtD
Midazolam—Vomiting—Irinotecan—lung cancer	8.42e-05	0.000589	CcSEcCtD
Midazolam—ABCB1—lung—lung cancer	8.4e-05	0.00545	CbGeAlD
Midazolam—Immune system disorder—Methotrexate—lung cancer	8.39e-05	0.000587	CcSEcCtD
Midazolam—Mediastinal disorder—Methotrexate—lung cancer	8.37e-05	0.000586	CcSEcCtD
Midazolam—Rash—Irinotecan—lung cancer	8.35e-05	0.000584	CcSEcCtD
Midazolam—Dermatitis—Irinotecan—lung cancer	8.34e-05	0.000584	CcSEcCtD
Midazolam—Chills—Methotrexate—lung cancer	8.34e-05	0.000583	CcSEcCtD
Midazolam—Headache—Irinotecan—lung cancer	8.3e-05	0.000581	CcSEcCtD
Midazolam—Paraesthesia—Docetaxel—lung cancer	8.22e-05	0.000575	CcSEcCtD
Midazolam—Clobazam—ABCB1—lung cancer	8.22e-05	0.0443	CrCbGaD
Midazolam—Vomiting—Gemcitabine—lung cancer	8.2e-05	0.000574	CcSEcCtD
Midazolam—Bradycardia—Doxorubicin—lung cancer	8.19e-05	0.000573	CcSEcCtD
Midazolam—Dyspnoea—Docetaxel—lung cancer	8.16e-05	0.000571	CcSEcCtD
Midazolam—Somnolence—Docetaxel—lung cancer	8.14e-05	0.00057	CcSEcCtD
Midazolam—Mental disorder—Methotrexate—lung cancer	8.14e-05	0.000569	CcSEcCtD
Midazolam—Rash—Gemcitabine—lung cancer	8.14e-05	0.000569	CcSEcCtD
Midazolam—Dermatitis—Gemcitabine—lung cancer	8.13e-05	0.000569	CcSEcCtD
Midazolam—Hypersensitivity—Etoposide—lung cancer	8.12e-05	0.000568	CcSEcCtD
Midazolam—Erythema—Methotrexate—lung cancer	8.09e-05	0.000566	CcSEcCtD
Midazolam—Headache—Gemcitabine—lung cancer	8.08e-05	0.000566	CcSEcCtD
Midazolam—Dyspepsia—Docetaxel—lung cancer	8.06e-05	0.000564	CcSEcCtD
Midazolam—Hypersensitivity—Paclitaxel—lung cancer	7.96e-05	0.000557	CcSEcCtD
Midazolam—Gastrointestinal disorder—Docetaxel—lung cancer	7.91e-05	0.000553	CcSEcCtD
Midazolam—Asthenia—Etoposide—lung cancer	7.91e-05	0.000553	CcSEcCtD
Midazolam—Connective tissue disorder—Doxorubicin—lung cancer	7.91e-05	0.000553	CcSEcCtD
Midazolam—Fatigue—Docetaxel—lung cancer	7.9e-05	0.000552	CcSEcCtD
Midazolam—Nausea—Irinotecan—lung cancer	7.87e-05	0.000551	CcSEcCtD
Midazolam—Pain—Docetaxel—lung cancer	7.83e-05	0.000548	CcSEcCtD
Midazolam—Constipation—Docetaxel—lung cancer	7.83e-05	0.000548	CcSEcCtD
Midazolam—Pruritus—Etoposide—lung cancer	7.8e-05	0.000545	CcSEcCtD
Midazolam—Visual impairment—Doxorubicin—lung cancer	7.75e-05	0.000542	CcSEcCtD
Midazolam—Asthenia—Paclitaxel—lung cancer	7.75e-05	0.000542	CcSEcCtD
Midazolam—Nausea—Gemcitabine—lung cancer	7.66e-05	0.000536	CcSEcCtD
Midazolam—Vomiting—Cisplatin—lung cancer	7.65e-05	0.000535	CcSEcCtD
Midazolam—Pruritus—Paclitaxel—lung cancer	7.64e-05	0.000535	CcSEcCtD
Midazolam—Vision blurred—Methotrexate—lung cancer	7.62e-05	0.000533	CcSEcCtD
Midazolam—Rash—Cisplatin—lung cancer	7.58e-05	0.000531	CcSEcCtD
Midazolam—Dermatitis—Cisplatin—lung cancer	7.58e-05	0.00053	CcSEcCtD
Midazolam—Feeling abnormal—Docetaxel—lung cancer	7.55e-05	0.000528	CcSEcCtD
Midazolam—Eye disorder—Doxorubicin—lung cancer	7.52e-05	0.000526	CcSEcCtD
Midazolam—Cardiac disorder—Doxorubicin—lung cancer	7.47e-05	0.000522	CcSEcCtD
Midazolam—Dizziness—Etoposide—lung cancer	7.29e-05	0.00051	CcSEcCtD
Midazolam—Immune system disorder—Doxorubicin—lung cancer	7.27e-05	0.000508	CcSEcCtD
Midazolam—Vertigo—Methotrexate—lung cancer	7.27e-05	0.000508	CcSEcCtD
Midazolam—Mediastinal disorder—Doxorubicin—lung cancer	7.25e-05	0.000507	CcSEcCtD
Midazolam—Chills—Doxorubicin—lung cancer	7.22e-05	0.000505	CcSEcCtD
Midazolam—Dizziness—Paclitaxel—lung cancer	7.14e-05	0.0005	CcSEcCtD
Midazolam—Nausea—Cisplatin—lung cancer	7.14e-05	0.0005	CcSEcCtD
Midazolam—Cough—Methotrexate—lung cancer	7.06e-05	0.000494	CcSEcCtD
Midazolam—Mental disorder—Doxorubicin—lung cancer	7.05e-05	0.000493	CcSEcCtD
Midazolam—Vomiting—Etoposide—lung cancer	7.01e-05	0.00049	CcSEcCtD
Midazolam—Erythema—Doxorubicin—lung cancer	7e-05	0.00049	CcSEcCtD
Midazolam—Rash—Etoposide—lung cancer	6.95e-05	0.000486	CcSEcCtD
Midazolam—Dermatitis—Etoposide—lung cancer	6.94e-05	0.000486	CcSEcCtD
Midazolam—Headache—Etoposide—lung cancer	6.9e-05	0.000483	CcSEcCtD
Midazolam—Tension—Doxorubicin—lung cancer	6.87e-05	0.000481	CcSEcCtD
Midazolam—Vomiting—Paclitaxel—lung cancer	6.87e-05	0.000481	CcSEcCtD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	6.84e-05	0.000478	CcSEcCtD
Midazolam—Rash—Paclitaxel—lung cancer	6.81e-05	0.000477	CcSEcCtD
Midazolam—Dermatitis—Paclitaxel—lung cancer	6.81e-05	0.000476	CcSEcCtD
Midazolam—Nervousness—Doxorubicin—lung cancer	6.8e-05	0.000476	CcSEcCtD
Midazolam—Headache—Paclitaxel—lung cancer	6.77e-05	0.000474	CcSEcCtD
Midazolam—Hypersensitivity—Docetaxel—lung cancer	6.75e-05	0.000472	CcSEcCtD
Midazolam—Confusional state—Methotrexate—lung cancer	6.66e-05	0.000466	CcSEcCtD
Midazolam—Anaphylactic shock—Methotrexate—lung cancer	6.6e-05	0.000462	CcSEcCtD
Midazolam—Vision blurred—Doxorubicin—lung cancer	6.6e-05	0.000462	CcSEcCtD
Midazolam—Asthenia—Docetaxel—lung cancer	6.57e-05	0.00046	CcSEcCtD
Midazolam—Nausea—Etoposide—lung cancer	6.55e-05	0.000458	CcSEcCtD
Midazolam—Pruritus—Docetaxel—lung cancer	6.48e-05	0.000453	CcSEcCtD
Midazolam—Nervous system disorder—Methotrexate—lung cancer	6.47e-05	0.000453	CcSEcCtD
Midazolam—Chlorprothixene—ABCB1—lung cancer	6.47e-05	0.0348	CrCbGaD
Midazolam—Agitation—Doxorubicin—lung cancer	6.44e-05	0.00045	CcSEcCtD
Midazolam—Nausea—Paclitaxel—lung cancer	6.42e-05	0.000449	CcSEcCtD
Midazolam—Skin disorder—Methotrexate—lung cancer	6.41e-05	0.000449	CcSEcCtD
Midazolam—Vertigo—Doxorubicin—lung cancer	6.29e-05	0.00044	CcSEcCtD
Midazolam—Syncope—Doxorubicin—lung cancer	6.28e-05	0.000439	CcSEcCtD
Midazolam—Hypotension—Methotrexate—lung cancer	6.17e-05	0.000431	CcSEcCtD
Midazolam—Cough—Doxorubicin—lung cancer	6.11e-05	0.000428	CcSEcCtD
Midazolam—Dizziness—Docetaxel—lung cancer	6.06e-05	0.000424	CcSEcCtD
Midazolam—Flurazepam—ABCB1—lung cancer	6.04e-05	0.0325	CrCbGaD
Midazolam—Anxiety—Doxorubicin—lung cancer	5.94e-05	0.000416	CcSEcCtD
Midazolam—Paraesthesia—Methotrexate—lung cancer	5.93e-05	0.000415	CcSEcCtD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	5.92e-05	0.000414	CcSEcCtD
Midazolam—Dyspnoea—Methotrexate—lung cancer	5.88e-05	0.000412	CcSEcCtD
Midazolam—Somnolence—Methotrexate—lung cancer	5.87e-05	0.000411	CcSEcCtD
Midazolam—Dry mouth—Doxorubicin—lung cancer	5.83e-05	0.000408	CcSEcCtD
Midazolam—Vomiting—Docetaxel—lung cancer	5.82e-05	0.000407	CcSEcCtD
Midazolam—Dyspepsia—Methotrexate—lung cancer	5.81e-05	0.000406	CcSEcCtD
Midazolam—Rash—Docetaxel—lung cancer	5.77e-05	0.000404	CcSEcCtD
Midazolam—Dermatitis—Docetaxel—lung cancer	5.77e-05	0.000404	CcSEcCtD
Midazolam—Confusional state—Doxorubicin—lung cancer	5.76e-05	0.000403	CcSEcCtD
Midazolam—ABCB1—lymph node—lung cancer	5.74e-05	0.00373	CbGeAlD
Midazolam—Headache—Docetaxel—lung cancer	5.74e-05	0.000401	CcSEcCtD
Midazolam—Anaphylactic shock—Doxorubicin—lung cancer	5.72e-05	0.0004	CcSEcCtD
Midazolam—Gastrointestinal disorder—Methotrexate—lung cancer	5.7e-05	0.000399	CcSEcCtD
Midazolam—Fatigue—Methotrexate—lung cancer	5.69e-05	0.000398	CcSEcCtD
Midazolam—Pain—Methotrexate—lung cancer	5.64e-05	0.000395	CcSEcCtD
Midazolam—Shock—Doxorubicin—lung cancer	5.62e-05	0.000393	CcSEcCtD
Midazolam—Nervous system disorder—Doxorubicin—lung cancer	5.6e-05	0.000392	CcSEcCtD
Midazolam—Tachycardia—Doxorubicin—lung cancer	5.58e-05	0.00039	CcSEcCtD
Midazolam—Skin disorder—Doxorubicin—lung cancer	5.55e-05	0.000388	CcSEcCtD
Midazolam—Nausea—Docetaxel—lung cancer	5.44e-05	0.000381	CcSEcCtD
Midazolam—Feeling abnormal—Methotrexate—lung cancer	5.44e-05	0.000381	CcSEcCtD
Midazolam—Hypotension—Doxorubicin—lung cancer	5.34e-05	0.000374	CcSEcCtD
Midazolam—Urticaria—Methotrexate—lung cancer	5.24e-05	0.000367	CcSEcCtD
Midazolam—Paraesthesia—Doxorubicin—lung cancer	5.13e-05	0.000359	CcSEcCtD
Midazolam—Dyspnoea—Doxorubicin—lung cancer	5.1e-05	0.000356	CcSEcCtD
Midazolam—Somnolence—Doxorubicin—lung cancer	5.08e-05	0.000355	CcSEcCtD
Midazolam—Dyspepsia—Doxorubicin—lung cancer	5.03e-05	0.000352	CcSEcCtD
Midazolam—Diazepam—ALB—lung cancer	5.03e-05	0.0271	CrCbGaD
Midazolam—Gastrointestinal disorder—Doxorubicin—lung cancer	4.93e-05	0.000345	CcSEcCtD
Midazolam—Fatigue—Doxorubicin—lung cancer	4.93e-05	0.000345	CcSEcCtD
Midazolam—Constipation—Doxorubicin—lung cancer	4.89e-05	0.000342	CcSEcCtD
Midazolam—Pain—Doxorubicin—lung cancer	4.89e-05	0.000342	CcSEcCtD
Midazolam—Hypersensitivity—Methotrexate—lung cancer	4.86e-05	0.00034	CcSEcCtD
Midazolam—Diazepam—ABCB1—lung cancer	4.8e-05	0.0258	CrCbGaD
Midazolam—Asthenia—Methotrexate—lung cancer	4.74e-05	0.000331	CcSEcCtD
Midazolam—Feeling abnormal—Doxorubicin—lung cancer	4.71e-05	0.000329	CcSEcCtD
Midazolam—Pruritus—Methotrexate—lung cancer	4.67e-05	0.000327	CcSEcCtD
Midazolam—Urticaria—Doxorubicin—lung cancer	4.54e-05	0.000318	CcSEcCtD
Midazolam—Dizziness—Methotrexate—lung cancer	4.36e-05	0.000305	CcSEcCtD
Midazolam—Hypersensitivity—Doxorubicin—lung cancer	4.21e-05	0.000295	CcSEcCtD
Midazolam—Vomiting—Methotrexate—lung cancer	4.2e-05	0.000294	CcSEcCtD
Midazolam—Rash—Methotrexate—lung cancer	4.16e-05	0.000291	CcSEcCtD
Midazolam—Dermatitis—Methotrexate—lung cancer	4.16e-05	0.000291	CcSEcCtD
Midazolam—Headache—Methotrexate—lung cancer	4.13e-05	0.000289	CcSEcCtD
Midazolam—Asthenia—Doxorubicin—lung cancer	4.1e-05	0.000287	CcSEcCtD
Midazolam—Pruritus—Doxorubicin—lung cancer	4.04e-05	0.000283	CcSEcCtD
Midazolam—Nausea—Methotrexate—lung cancer	3.92e-05	0.000274	CcSEcCtD
Midazolam—Dizziness—Doxorubicin—lung cancer	3.78e-05	0.000264	CcSEcCtD
Midazolam—Vomiting—Doxorubicin—lung cancer	3.63e-05	0.000254	CcSEcCtD
Midazolam—Rash—Doxorubicin—lung cancer	3.6e-05	0.000252	CcSEcCtD
Midazolam—Dermatitis—Doxorubicin—lung cancer	3.6e-05	0.000252	CcSEcCtD
Midazolam—Headache—Doxorubicin—lung cancer	3.58e-05	0.00025	CcSEcCtD
Midazolam—Nausea—Doxorubicin—lung cancer	3.39e-05	0.000238	CcSEcCtD
Midazolam—CYP3A4—Metabolism—PLBD1—lung cancer	7.2e-06	5.8e-05	CbGpPWpGaD
Midazolam—ABCB1—Transmembrane transport of small molecules—AVP—lung cancer	7.18e-06	5.79e-05	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	7.14e-06	5.76e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—NCOA3—lung cancer	7.12e-06	5.74e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—CYP2E1—lung cancer	7.12e-06	5.74e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—NCOA3—lung cancer	7.11e-06	5.73e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—B4GALT5—lung cancer	7.08e-06	5.7e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—ABCG2—lung cancer	7.07e-06	5.7e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—ADCY1—lung cancer	7.07e-06	5.7e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—NQO1—lung cancer	7.04e-06	5.67e-05	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	6.95e-06	5.6e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—ENO2—lung cancer	6.94e-06	5.59e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—HPGDS—lung cancer	6.94e-06	5.59e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—ADCY1—lung cancer	6.93e-06	5.59e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—ABCG2—lung cancer	6.93e-06	5.59e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—ADCY1—lung cancer	6.91e-06	5.57e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—ABCG2—lung cancer	6.91e-06	5.57e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—PPP2R1B—lung cancer	6.89e-06	5.56e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—GSTA4—lung cancer	6.88e-06	5.55e-05	CbGpPWpGaD
Midazolam—SLC22A1—Neuronal System—HRAS—lung cancer	6.87e-06	5.54e-05	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—PIK3CB—lung cancer	6.83e-06	5.5e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—STK11—lung cancer	6.82e-06	5.49e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—HPGDS—lung cancer	6.79e-06	5.48e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—ENO2—lung cancer	6.79e-06	5.48e-05	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	6.79e-06	5.48e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—HPGDS—lung cancer	6.78e-06	5.47e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—ENO2—lung cancer	6.78e-06	5.47e-05	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—PTGS2—lung cancer	6.76e-06	5.45e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—PPP2R1B—lung cancer	6.75e-06	5.44e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—PPP2R1B—lung cancer	6.74e-06	5.43e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—GSTT1—lung cancer	6.73e-06	5.42e-05	CbGpPWpGaD
Midazolam—SLC22A1—Transmembrane transport of small molecules—RAF1—lung cancer	6.71e-06	5.41e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—GSTA2—lung cancer	6.71e-06	5.41e-05	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—PIK3CA—lung cancer	6.65e-06	5.36e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—CYP2A6—lung cancer	6.65e-06	5.36e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—GCLC—lung cancer	6.65e-06	5.36e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—GSTT1—lung cancer	6.59e-06	5.31e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—HSD17B10—lung cancer	6.58e-06	5.31e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—GSTT1—lung cancer	6.58e-06	5.3e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—GCLC—lung cancer	6.51e-06	5.25e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—CYP2A6—lung cancer	6.51e-06	5.25e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—GCLC—lung cancer	6.5e-06	5.24e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—CYP2A6—lung cancer	6.5e-06	5.24e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—GSTA1—lung cancer	6.47e-06	5.22e-05	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	6.42e-06	5.17e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—ABCC3—lung cancer	6.4e-06	5.16e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—STK11—lung cancer	6.34e-06	5.11e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—GSTP1—lung cancer	6.31e-06	5.08e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—ENO1—lung cancer	6.31e-06	5.08e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—AKR1C1—lung cancer	6.2e-06	5e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—ENO1—lung cancer	6.18e-06	4.98e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—ENO1—lung cancer	6.16e-06	4.97e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—CAT—lung cancer	6.14e-06	4.95e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—CKB—lung cancer	6.12e-06	4.93e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—UGT1A1—lung cancer	6.02e-06	4.85e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—ABCB1—lung cancer	5.97e-06	4.81e-05	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—PTEN—lung cancer	5.9e-06	4.75e-05	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	5.9e-06	4.75e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—GSTP1—lung cancer	5.87e-06	4.73e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—TYMS—lung cancer	5.86e-06	4.73e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—GNG11—lung cancer	5.8e-06	4.68e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—GSTM1—lung cancer	5.8e-06	4.67e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—CNDP2—lung cancer	5.75e-06	4.64e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—GSTM2—lung cancer	5.75e-06	4.64e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—CAT—lung cancer	5.71e-06	4.6e-05	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	5.7e-06	4.6e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—CYP2E1—lung cancer	5.66e-06	4.56e-05	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—EP300—lung cancer	5.63e-06	4.53e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—MTMR3—lung cancer	5.6e-06	4.51e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—NQO1—lung cancer	5.59e-06	4.51e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—ABCB1—lung cancer	5.56e-06	4.48e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—CYP2E1—lung cancer	5.53e-06	4.46e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—ALDOA—lung cancer	5.53e-06	4.45e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—CYP1A1—lung cancer	5.49e-06	4.43e-05	CbGpPWpGaD
Midazolam—ABCB1—Transmembrane transport of small molecules—APOA1—lung cancer	5.49e-06	4.42e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—NQO1—lung cancer	5.48e-06	4.41e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—NQO1—lung cancer	5.47e-06	4.41e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—TYMS—lung cancer	5.46e-06	4.4e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PGAM1—lung cancer	5.45e-06	4.4e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—ERCC2—lung cancer	5.45e-06	4.39e-05	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—AKT1—lung cancer	5.43e-06	4.38e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—GSTM1—lung cancer	5.39e-06	4.35e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—NCOA3—lung cancer	5.36e-06	4.32e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—ADCY1—lung cancer	5.22e-06	4.21e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—ABCG2—lung cancer	5.22e-06	4.21e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—CYP2A7—lung cancer	5.2e-06	4.19e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—HPGDS—lung cancer	5.12e-06	4.12e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—ENO2—lung cancer	5.12e-06	4.12e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—CYP1A1—lung cancer	5.11e-06	4.12e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—SDC4—lung cancer	5.09e-06	4.1e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—PPP2R1B—lung cancer	5.08e-06	4.1e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—ERCC2—lung cancer	5.07e-06	4.09e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—STK11—lung cancer	5.04e-06	4.06e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—GSTT1—lung cancer	4.96e-06	4e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—STK11—lung cancer	4.94e-06	3.98e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—STK11—lung cancer	4.93e-06	3.97e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—GCLC—lung cancer	4.91e-06	3.95e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—CYP2A6—lung cancer	4.91e-06	3.95e-05	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	4.82e-06	3.88e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—APOA1—lung cancer	4.71e-06	3.8e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—GSTP1—lung cancer	4.66e-06	3.76e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—ENO1—lung cancer	4.65e-06	3.75e-05	CbGpPWpGaD
Midazolam—ABCB1—Transmembrane transport of small molecules—CREBBP—lung cancer	4.65e-06	3.75e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—RRM1—lung cancer	4.64e-06	3.74e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—GSTA3—lung cancer	4.64e-06	3.74e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—GSTP1—lung cancer	4.57e-06	3.68e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—GSTP1—lung cancer	4.56e-06	3.67e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—CAT—lung cancer	4.54e-06	3.66e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—CAT—lung cancer	4.45e-06	3.58e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—CAT—lung cancer	4.44e-06	3.58e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—ABCB1—lung cancer	4.41e-06	3.56e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—APOA1—lung cancer	4.39e-06	3.54e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—B4GALT5—lung cancer	4.36e-06	3.51e-05	CbGpPWpGaD
Midazolam—ABCB1—Transmembrane transport of small molecules—ALB—lung cancer	4.35e-06	3.51e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—TYMS—lung cancer	4.34e-06	3.5e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—ABCB1—lung cancer	4.32e-06	3.49e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—ABCB1—lung cancer	4.32e-06	3.48e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—PIK3CG—lung cancer	4.3e-06	3.47e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—GSTM1—lung cancer	4.29e-06	3.45e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—TYMS—lung cancer	4.25e-06	3.42e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—GSTA4—lung cancer	4.24e-06	3.42e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—TYMS—lung cancer	4.24e-06	3.42e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—GSTM1—lung cancer	4.2e-06	3.38e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—GSTM1—lung cancer	4.19e-06	3.38e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—CYP2E1—lung cancer	4.17e-06	3.36e-05	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—PIK3CA—lung cancer	4.16e-06	3.35e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—GSTA2—lung cancer	4.13e-06	3.33e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—NQO1—lung cancer	4.12e-06	3.32e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—POMC—lung cancer	4.1e-06	3.3e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—CYP1A1—lung cancer	4.06e-06	3.28e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—ERCC2—lung cancer	4.03e-06	3.25e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—PIK3CG—lung cancer	4e-06	3.23e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—CREBBP—lung cancer	3.99e-06	3.22e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—GSTA1—lung cancer	3.99e-06	3.21e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—CYP1A1—lung cancer	3.98e-06	3.21e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—CYP1A1—lung cancer	3.97e-06	3.2e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—ERCC2—lung cancer	3.95e-06	3.18e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—ABCC3—lung cancer	3.94e-06	3.18e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—ERCC2—lung cancer	3.94e-06	3.17e-05	CbGpPWpGaD
Midazolam—ABCB1—Transmembrane transport of small molecules—RAF1—lung cancer	3.93e-06	3.17e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—AKR1C1—lung cancer	3.82e-06	3.08e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—POMC—lung cancer	3.81e-06	3.07e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—PIK3CD—lung cancer	3.78e-06	3.05e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—ALB—lung cancer	3.73e-06	3.01e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—STK11—lung cancer	3.72e-06	3e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—CREBBP—lung cancer	3.71e-06	2.99e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—UGT1A1—lung cancer	3.71e-06	2.99e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—GNG11—lung cancer	3.58e-06	2.88e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—PIK3CD—lung cancer	3.52e-06	2.84e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—APOA1—lung cancer	3.49e-06	2.81e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—ALB—lung cancer	3.48e-06	2.8e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—GSTP1—lung cancer	3.44e-06	2.77e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—APOA1—lung cancer	3.41e-06	2.75e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—APOA1—lung cancer	3.41e-06	2.75e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—ALDOA—lung cancer	3.4e-06	2.74e-05	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—AKT1—lung cancer	3.4e-06	2.74e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—CAT—lung cancer	3.35e-06	2.7e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—NCOA3—lung cancer	3.3e-06	2.66e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—PIK3CB—lung cancer	3.3e-06	2.66e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—PTGS2—lung cancer	3.27e-06	2.63e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—ADCY1—lung cancer	3.21e-06	2.59e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—ABCG2—lung cancer	3.21e-06	2.59e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—TYMS—lung cancer	3.2e-06	2.58e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—PIK3CG—lung cancer	3.18e-06	2.57e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—GSTM1—lung cancer	3.16e-06	2.55e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—HPGDS—lung cancer	3.15e-06	2.54e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—ENO2—lung cancer	3.15e-06	2.54e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PPP2R1B—lung cancer	3.13e-06	2.53e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—PIK3CG—lung cancer	3.12e-06	2.51e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—PIK3CG—lung cancer	3.11e-06	2.51e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—PIK3CB—lung cancer	3.07e-06	2.47e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—GSTT1—lung cancer	3.06e-06	2.46e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—PTGS2—lung cancer	3.04e-06	2.45e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—POMC—lung cancer	3.03e-06	2.44e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—CYP2A6—lung cancer	3.02e-06	2.44e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—GCLC—lung cancer	3.02e-06	2.44e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—CYP1A1—lung cancer	3e-06	2.42e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—ERCC2—lung cancer	2.97e-06	2.4e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—POMC—lung cancer	2.97e-06	2.39e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—POMC—lung cancer	2.96e-06	2.39e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—CREBBP—lung cancer	2.95e-06	2.38e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—CREBBP—lung cancer	2.89e-06	2.33e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—CREBBP—lung cancer	2.88e-06	2.32e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—ENO1—lung cancer	2.87e-06	2.31e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—PTEN—lung cancer	2.85e-06	2.3e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—PIK3CD—lung cancer	2.8e-06	2.26e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—ALB—lung cancer	2.76e-06	2.23e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—PIK3CD—lung cancer	2.74e-06	2.21e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—PIK3CD—lung cancer	2.73e-06	2.2e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—EP300—lung cancer	2.72e-06	2.19e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—ALB—lung cancer	2.71e-06	2.18e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—ALB—lung cancer	2.7e-06	2.18e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—PTEN—lung cancer	2.65e-06	2.14e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—APOA1—lung cancer	2.57e-06	2.07e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—CYP2E1—lung cancer	2.57e-06	2.07e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—NQO1—lung cancer	2.54e-06	2.05e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—EP300—lung cancer	2.53e-06	2.04e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—PIK3CB—lung cancer	2.44e-06	1.97e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—PTGS2—lung cancer	2.42e-06	1.95e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—PIK3CB—lung cancer	2.39e-06	1.93e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—PIK3CB—lung cancer	2.38e-06	1.92e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—PTGS2—lung cancer	2.37e-06	1.91e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—PTGS2—lung cancer	2.36e-06	1.9e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—PIK3CG—lung cancer	2.35e-06	1.89e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—STK11—lung cancer	2.29e-06	1.85e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—POMC—lung cancer	2.23e-06	1.8e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—CREBBP—lung cancer	2.18e-06	1.75e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—GSTP1—lung cancer	2.12e-06	1.71e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—PTEN—lung cancer	2.11e-06	1.7e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—PTEN—lung cancer	2.06e-06	1.66e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—PIK3CD—lung cancer	2.06e-06	1.66e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—CAT—lung cancer	2.06e-06	1.66e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—PTEN—lung cancer	2.06e-06	1.66e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—ALB—lung cancer	2.04e-06	1.64e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—PIK3CA—lung cancer	2.01e-06	1.62e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—EP300—lung cancer	2.01e-06	1.62e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—ABCB1—lung cancer	2.01e-06	1.62e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—TYMS—lung cancer	1.97e-06	1.59e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—EP300—lung cancer	1.97e-06	1.59e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—EP300—lung cancer	1.96e-06	1.58e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—GSTM1—lung cancer	1.95e-06	1.57e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—PIK3CA—lung cancer	1.87e-06	1.51e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—CYP1A1—lung cancer	1.85e-06	1.49e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—ERCC2—lung cancer	1.83e-06	1.48e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—PIK3CB—lung cancer	1.8e-06	1.45e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—PTGS2—lung cancer	1.78e-06	1.44e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—AKT1—lung cancer	1.64e-06	1.32e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—APOA1—lung cancer	1.58e-06	1.28e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—PTEN—lung cancer	1.55e-06	1.25e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—AKT1—lung cancer	1.53e-06	1.23e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—PIK3CA—lung cancer	1.49e-06	1.2e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—EP300—lung cancer	1.48e-06	1.19e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—PIK3CA—lung cancer	1.46e-06	1.17e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—PIK3CA—lung cancer	1.45e-06	1.17e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PIK3CG—lung cancer	1.45e-06	1.17e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—POMC—lung cancer	1.38e-06	1.11e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—CREBBP—lung cancer	1.34e-06	1.08e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PIK3CD—lung cancer	1.27e-06	1.02e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—ALB—lung cancer	1.26e-06	1.01e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—AKT1—lung cancer	1.21e-06	9.79e-06	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—AKT1—lung cancer	1.19e-06	9.59e-06	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—AKT1—lung cancer	1.19e-06	9.57e-06	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PIK3CB—lung cancer	1.11e-06	8.93e-06	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PTGS2—lung cancer	1.1e-06	8.85e-06	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—PIK3CA—lung cancer	1.1e-06	8.84e-06	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PTEN—lung cancer	9.58e-07	7.72e-06	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—EP300—lung cancer	9.13e-07	7.36e-06	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—AKT1—lung cancer	8.96e-07	7.22e-06	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PIK3CA—lung cancer	6.76e-07	5.45e-06	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—AKT1—lung cancer	5.52e-07	4.45e-06	CbGpPWpGaD
